Literature DB >> 26788174

False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literature.

Yi-Shan Yu1, Wan-Hu Li2, Ming-Huan Li1, Xue Meng1, L I Kong1, Jin-Ming Yu1.   

Abstract

Bone metastases are common in prostate cancer. However, differentiating neoplastic from non-neoplastic alterations of bone on images is challenging. In the present report, a rare case of bone marrow reconversion on magnetic resonance imaging (MRI) assessment, which may lead to a false-positive diagnosis of disease progression of bone metastases in hormone-resistant prostate cancer, is presented. Furthermore, a review of the literature regarding the pitfalls of images for response assessment, including the 'flare' phenomenon on bone scintigraphy, computed tomography (CT), positron emission tomography/CT and marrow reconversion on MRI is also provided. These inaccuracies, which may lead to a premature termination of an efficacious treatment, should be carefully considered by the radiologists and oncologists involved in clinical trials. The case reported in the present study showed how to assess the early therapeutic response and select the appropriate treatment for the patient when these pitfalls are encountered on clinical images.

Entities:  

Keywords:  marrow reconversion on magnetic resonance imaging; pitfalls of images; prostate cancer; ‘flare’ phenomenon

Year:  2015        PMID: 26788174      PMCID: PMC4665215          DOI: 10.3892/ol.2015.3753

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response.

Authors:  Charles J Ryan; Shreya Shah; Eleni Efstathiou; Matthew R Smith; Mary-Ellen Taplin; Glenn J Bubley; Christopher J Logothetis; Thian Kheoh; Christine Kilian; Christopher M Haqq; Arturo Molina; Eric J Small
Journal:  Clin Cancer Res       Date:  2011-06-01       Impact factor: 12.531

2.  Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.

Authors:  Kaye L Johnston; John P Farnen; Brian R Manske; Ronald S Go
Journal:  Haematologica       Date:  2005-12       Impact factor: 9.941

Review 3.  Bone marrow imaging.

Authors:  J B Vogler; W A Murphy
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

4.  Effects of radiation therapy on bone lesions as measured by 47 Ca and 85 Sr local kinetics.

Authors:  E J Greenburg; F C Chu; A J Dwyer; E M Ziminski; A B Dimich; J S Laughlin
Journal:  J Nucl Med       Date:  1972-10       Impact factor: 10.057

5.  In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water.

Authors:  D G Disler; T R McCauley; L M Ratner; C D Kesack; J A Cooper
Journal:  AJR Am J Roentgenol       Date:  1997-11       Impact factor: 3.959

6.  Healing flare in skeletal metastases from breast cancer.

Authors:  M J Janicek; D F Hayes; W D Kaplan
Journal:  Radiology       Date:  1994-07       Impact factor: 11.105

7.  The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.

Authors:  J J Pollen; K F Witztum; W L Ashburn
Journal:  AJR Am J Roentgenol       Date:  1984-04       Impact factor: 3.959

Review 8.  Epidemiology of Prostate Cancer.

Authors:  Muhammad Naeem Bashir
Journal:  Asian Pac J Cancer Prev       Date:  2015

9.  Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy.

Authors:  Thomas Nelius; Tobias Klatte; Werner de Riese; Stephanie Filleur
Journal:  Int Urol Nephrol       Date:  2007-06-30       Impact factor: 2.370

Review 10.  Imaging metastatic bone disease from carcinoma of the prostate.

Authors:  C Messiou; G Cook; N M deSouza
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more
  6 in total

1.  Bone marrow reconversion mimicking pelvis metastases in a patient with rectal cancer: a pitfall on magnetic resonance images.

Authors:  Feng Zhao; Jiayan Shen; Xiaokai Yu; Hua Zhou; Zhongjie Lu; Senxiang Yan
Journal:  Quant Imaging Med Surg       Date:  2018-07

Review 2.  The future of PSMA PET and WB MRI as next-generation imaging tools in prostate cancer.

Authors:  Yishen Wang; Joao R Galante; Athar Haroon; Simon Wan; Asim Afaq; Heather Payne; Jamshed Bomanji; Sola Adeleke; Veeru Kasivisvanathan
Journal:  Nat Rev Urol       Date:  2022-07-04       Impact factor: 16.430

3.  A Pitfall for Diffusion-weighted MR Imaging When Assessing the Response to Neoadjuvant Chemotherapy in Ewing Sarcoma.

Authors:  Ömer Kasalak; Albert J H Suurmeijer; Jacco J De Haan; Hugo J A Adams; Paul C Jutte; Thomas C Kwee
Journal:  Magn Reson Med Sci       Date:  2018-12-06       Impact factor: 2.471

Review 4.  Clinical perspectives of PSMA PET/MRI for prostate cancer.

Authors:  Felipe de Galiza Barbosa; Marcelo Araújo Queiroz; Rafael Fernandes Nunes; José Flávio Gomes Marin; Carlos Alberto Buchpiguel; Giovanni Guido Cerri
Journal:  Clinics (Sao Paulo)       Date:  2018-09-21       Impact factor: 2.365

5.  A Flare for the Unexpected: Bone Flare as Response to Tyrosine Kinase Inhibitor Treatment in a Lung Cancer Patient: New osteoblastic bone lesions in a lung cancer patient may represent bone flare and should not be misdiagnosed as disease progression.

Authors:  Charlotte De Bondt; Annemiek Snoeckx; Jo Raskin
Journal:  J Belg Soc Radiol       Date:  2020-04-27       Impact factor: 1.894

6.  Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer.

Authors:  Mingxi Lin; Yizi Jin; Ziyi Yang; Xichun Hu; Jian Zhang
Journal:  Ther Adv Med Oncol       Date:  2021-06-15       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.